sirisha's blog
QUICK GLANCE OF DRUGS....
Submitted by Sirisha Pingali on Tue, 11/17/2009 - 13:49LYSTEDA (tranexamic acid) Tablets
Date of Approval: November 16, 2009
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Menorrhagia
ISTODAX (romidepsin) for Injection
Date of Approval: November 5, 2009
Company: Gloucester Pharmaceuticals
Treatment for: Cutaneous T-cell Lymphoma
PENNSAID(diclofenac sodium) Topical Solution
Date of Approval: November 4, 2009
- 6 comments
- Read more
- 137 reads
EARLY USE OF NSAID'S MIGHT PREVENT ALZHEIMER'S DISEASE..
Submitted by Sirisha Pingali on Tue, 11/10/2009 - 16:36As everyone are aware of Alzheimer's disease, recent news is that early use of NSAID's might prevent this disease. Its still under clinical investigation, the mice being the experimental animals.
Alzheimer’s disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks.
- 13 comments
- Read more
- 198 reads
POLYPILL...
Submitted by Sirisha Pingali on Wed, 10/28/2009 - 15:40Dear all..This is somewhat introduction to my previous blog "ExforgeHCT". 3 drugs within same pill leads to the concept of Polypill.
Whats a Polypill?
A polypill is dosage form or medication containing two or more active drugs. These are generally made on the intention of reducing the number of tablets or capsules to be taken.
- 5 comments
- Read more
- 333 reads
ExforgeHCT
Submitted by Sirisha Pingali on Sun, 10/25/2009 - 12:46Dear all..
We the members of THE COGNITIVE MOLECULES could not submit the blogs because of our semester end exams. Anyways we are back with a bang..Lets start a new blog..its EXFORGE HCT..
- 7 comments
- Read more
- 258 reads
Influenza A (H1N1) 2009 Monovalent Vaccine
Submitted by Sirisha Pingali on Fri, 10/09/2009 - 15:10Influenza A (H1N1) 2009 Monovalent Vaccine is developed by Novartis Vaccines and Diagnostics Ltd. Given as suspension for Intramuscular Injection
INDICATIONS AND USAGE
• Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 4 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus
- 2 comments
- Read more
- 355 reads
SITAGLIPTIN...Controversy vs Explanation
Submitted by Sirisha Pingali on Wed, 09/30/2009 - 04:30Recently FDA notified healthcare professionals that Januvia (sitagliptin) and Janumet (sitagliptin/metformin) are known to cause severe pancreatitis as on Sep 25th. Following this alert, Merck responded in the following way..
- 15 comments
- Read more
- 259 reads
FDA approves STELARA
Submitted by Sirisha Pingali on Sun, 09/27/2009 - 05:30In a recent news..FDA approved Stelara(ustekinumab)for adults to treat moderate to severe form of PSORIASIS.Plaque psoriasis is an immune system disorder that results in the rapid overproduction of skin cells. About 6 million people in the United States have plaque psoriasis which is characterized by thickened patches of inflamed, red skin, often covered with silvery scales.
- 7 comments
- Read more
- 139 reads
TAMIFLU...SIDE EFFECTS..
Submitted by Sirisha Pingali on Fri, 09/25/2009 - 15:45With the severe spreading of Swine flu..Doctors are prescribing TAMIFLU as preventive medication..But everyone should be aware of possible side effects by using the drug..Let's see some of the possible side effects of tamiflu..
Encourage patients to seek medical attention right away if any of these SEVERE side effects were observed..
- 14 comments
- Read more
- 622 reads
Matrix Signs Agreement with Clinton Foundation for ARV Drugs...
Submitted by Sirisha Pingali on Mon, 09/21/2009 - 03:18The two companies have come to a deal in the year 2007 but most of us are unaware of this..
- 6 comments
- Read more
- 339 reads
Orchid's Piperacillin-Tazobactam ANDA gets FDA nod
Submitted by Sirisha Pingali on Wed, 09/16/2009 - 15:40India based pharma major - Orchid Chemicals and Pharmaceuticals has received approvals from FDA for its ANDAs for Piperacillin and Tazobactam. These are available in both vial and Bulk Dosage forms. Orchid is the "first applicant" and a 180day generic drug exclusivity was granted by FDA. The Indian firm has marketing and distribution partnership with Apotex a US based company.
- 11 comments
- Read more
- 517 reads

